Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

As China's biotech sector matures, companies are striving to reconcile their bold innovation goals with a healthcare system ...

Meanwhile, BioNTech itself bought into the category with its takeover of BNT327's developer Biotheus unit last year for what now looks like a knockdown price of $800 million, ...

BioNTech has agreed to buy another specialist in mRNA-based vaccines and therapeutics, fellow German biotech CureVac, in an all-stock deal valued at around $1.25 billion.

See the latest BioNTech SE ADR stock price (BNTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

See the latest Bristol-Myers Squibb Co stock price (BMY:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

A high-level overview of Summit Therapeutics Inc. (SMMT) stock. View (SMMT) real-time stock price, chart, news, analysis, analyst reviews and more.

Greg Meyers currently works at Bristol Myers Squibb Co., as Chief Digital & Technology Officer. Mr. Meyers also formerly worked at Syngenta Group Co., Ltd., as Group Chief Information & Digital ...